欧洲癌症研究与治疗组织(EORTC)更新版黑色素瘤前哨淋巴结病理评估方案
欧洲癌症研究与治疗组织(EORTC)黑色素瘤组制定了更新版前哨淋巴结组织病理学检查与报告方案,推荐根据淋巴结短轴尺寸调整切片间距,优化常规切片与染色流程(包括免疫组化),并规范黑色素瘤沉积灶空间定位描述及报告特征。该方案旨在简化现有流程、控制实验室与病理医生工作负荷并节约成本,同时不损失或可能提高准确性。
要点
- 推荐根据淋巴结短轴尺寸调整切片间距。
- 优化常规切片与染色流程,包括免疫组化。
- 报告应包括转移灶有无、结内位置、数目、最大径及有无包膜外扩展和痣细胞。
核心结论
- 更新版EORTC方案预期可阐明并简化现有流程,为实验室和病理医生提供合理工作量,在节约成本的同时不损失或可能提高准确性。
研究设计与样本
- 欧洲癌症研究与治疗组织(EORTC)黑色素瘤组制定更新版前哨淋巴结组织病理学检查与报告方案。
主要发现
- 推荐根据淋巴结短轴尺寸调整切片间距。
- 优化常规切片与染色流程,包括免疫组化。
- 提供前哨淋巴结中黑色素瘤沉积灶空间定位的描述指导。
关键数值与推荐
- 报告特征包括:转移灶有无、结内位置(包膜下、实质、混合、广泛融合、广泛多灶)、转移灶数目(1、2-5、6-10、11-20、>20)、最大转移灶最大径(注明部位)、包膜外扩展及痣细胞有无。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The sentinel lymph node (SLN) biopsy is a highly accurate staging procedure and the most important prognostic factor in melanoma patients. The European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group aimed to design an updated evolved SLN protocol for the histopathological workup and reporting. We herein recommend extending the distance between steps according to the short axis dimension of the lymph node and optimise both conventional sectioning and staining procedures including immunohistochemistry. We also provide guidance on the description of the spatial localisation of melanoma deposits in a SLN. The histopathological features to be reported include the following: presence or absence of the metastasis, the intranodal location of the metastasis (subcapsular, parenchymal, combined, extensive confluent and extensive multifocal), the number of the metastatic deposits (1, 2-5, 6-10, 11-20 and >20), the maximum dimension of the largest metastasis (indicating its site) and the presence of extracapsular extension and of naevus cells. This updated EORTC protocol is expected to clarify and simplify the existing procedures, ensuring a reasonable workload for the laboratory and for the pathologists resulting in cost saving with no loss, and possible increase, in accuracy.
引用
- Cook MG, Massi D, Szumera-Ciećkiewicz A, et al. An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma. Eur J Cancer. 2019. PMID: 31005015. doi:10.1016/j.ejca.2019.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。